- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04587804
Abdomen - Fat Reduction and Muscle Toning
Abdominal Treatment With Simultaneous Application of Noninvasive Repetitive Pulse Magnetic Stimulation (rPMS) and Radiofrequency
Study Overview
Detailed Description
This study will evaluate the clinical efficacy and safety of a simultaneous treatment by repetitive pulse magnetic stimulation and radiofrequency energy for toning of abdomen and reduction of subcutaneous fat. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete three (3) treatment visits and two to three follow-up visits. All of the study subjects will receive the treatment with the subject device.
At the baseline visit MRI will be performed, subject's weight and waist circumference will be recorded. Photos of the treated area will be taken.
The treatment administration phase will consist of three (3) treatments, delivered once a week. The applicator will be applied over umbilicus and visible muscle contractions along with heating of the subcutaneous fat will be induced by the device.
At the last therapy visit, the subject's weight and waist circumference will be recorded, and photos of the treated area will be taken. In addition, subjects will receive Subject Satisfaction Questionnaire to fill in.
Safety measures will include documentation of adverse events (AE) including subject's experience of pain or discomfort after each procedure. Following each treatment administration and at all of the follow-up visits, subjects will be checked for immediate post-procedure adverse event assessment.
During the post-procedure visits (at 1-month and 3-month follow-up visits), the subjects will undergo MRI scanning. Also, subject's satisfaction will be noted and weight with waist circumference will be recorded. Photographs of the treated area will be taken. There will be an option of a 6-months follow-up visit, according to subject's availability.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Macon, Georgia, United States, 31217
- Skin Care Physicians of Georgia
-
-
Illinois
-
Chicago, Illinois, United States, 60654
- Chicago Cosmetic Surgery and Dermatology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 21 years
- Voluntarily signed informed consent form
- BMI ≤ 35 kg/m2
- Women of child-bearing potential are required to use birth control measures during the whole duration of the study
- Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation
- Subjects willing and able to maintain her regular (pre-procedure) diet and exercise regimen without affecting significant change in either direction during study participation
Exclusion Criteria:
- Electronic implants (such as cardiac pacemakers, defibrillators and neurostimulators)
- Metal implants
- Drug pumps
- Malignant tumour
- Pulmonary insufficiency
- Injured or otherwise impaired muscles
- Cardiovascular diseases
- Disturbance of temperature or pain perception
- Hemorrhagic conditions
- Septic conditions and empyema
- Acute inflammations
- Systemic or local infection such as osteomyelitis and tuberculosis
- Contagious skin disease
- Elevated body temperature
- Pregnancy, postpartum period, nursing, and menstruation
- Intrauterine device (IUD)
- Swollen or neoplastic tissues, space occupying lesions or skin eruptions in the treatment area
- Basedow's disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Abdominal Toning and Reduction of Subcutaneous Fat
simultaneous treatment by repetitive pulse magnetic stimulation and radiofrequency energy for toning of abdomen and reduction of subcutaneous fat
|
The treatment administration phase will consist of three (3) treatments, delivered once a week.
The applicator of the device will be applied over umbilicus and visible muscle contractions along with heating of the subcutaneous fat will be induced by the device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of change in adipose and muscular layer thickness between pre-treatment and post-treatment based on MRI scans
Time Frame: 4 months
|
MRI will be conducted at the baseline visit and all follow-up visits. The imaging will be conducted at the same surface area each time. Hospital-grade MRI device will be used to scan abdominal area of each subject. The MRI scan without any contrast agent will be performed, with the scanned body segment determined by vertebrae T12 and S1. Lateral cuts from 5 cm below the umbilicus and 5 cm above the umbilicus will be evaluated for the thickness of muscle and subcutaneous adipose tissue. |
4 months
|
Evaluation of change in adipose layer thickness between pre-treatment and post-treatment based on waist circumference measurements
Time Frame: 4 months
|
Waist circumference measure will be conducted at the baseline visit, after last treatment and during follow-up visits. The waist circumference measure will be made at the top of the subject's iliac crest, with the tape held snugly, but not constricting, and at a level parallel to the floor. For the measurement, a stretch-resistant tape will be used. During the measuring, subject will stand with arms at the side, feet positioned close together, and weight evenly distributed across the feet. The subject will be instructed to relax and take a few deep, natural breaths before the actual measurement is made. The subjects will be measured in underwear only, after voiding the bladder. |
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of subject's satisfaction with the treatment using the Subject Satisfaction Questionnaire
Time Frame: 7 months
|
The 5-point Likert scale Satisfaction questionnaire will be used to evaluate the participant's satisfaction with the therapy outcome with answer "Strongly agree" being the most positive outcome and "Strongly disagree" the most negative.
Subject satisfaction will be assessed after the last therapy visit and during the follow-up visits.
|
7 months
|
Safety of the device measured via the occurrence of adverse events or lack thereof
Time Frame: 7 months
|
The occurrence of adverse events will be followed throughout the whole study.
|
7 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BTL-703_100
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fat Burn
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.CompletedFat BurnUnited States
-
BTL Industries Ltd.WithdrawnFat BurnUnited States, Bulgaria
-
São Paulo State UniversityUnknown
-
National Tainan Junior College of NursingCompleted
-
BTL Industries Ltd.CompletedFat BurnUnited States
-
BTL Industries Ltd.Active, not recruitingFat BurnUnited States
-
BTL Industries Ltd.Completed
-
National Taiwan UniversityCompleted
Clinical Trials on rPMS+RF
-
Chang Gung Memorial HospitalRecruiting
-
BTL Industries Ltd.CompletedUrinary IncontinenceUnited States
-
University of RegensburgCompletedChronic TinnitusGermany
-
BTL Industries Ltd.CompletedUrinary IncontinenceUnited States
-
University of Illinois at ChicagoRecruiting
-
Home Skinovations Ltd.CompletedGingivitis | Plaque | Calculus, DentalUnited States
-
GiMer MedicalCompletedLow Back Pain | Chronic Pain | Lower Limb PainTaiwan
-
Venclose, Inc.CompletedChronic Venous InsufficiencyGermany
-
Syneron MedicalCompletedSkin Resurfacing | Wrinkle ReductionUnited States, Canada
-
BTL Industries Ltd.CompletedCircumferential Reduction | Waist Circumferential Reduction